Evidence map›Paper›PMID 40770756›Full record

ArticleJournal of translational medicine2025

School-level prediction and management of myopia in children and adolescents.

Shengsong Xu, Linling Li, Yingting Zhu, Zhenbang Ruan, Yiwen Qu, Zhuandi Zhou, Yin Hu, Zhidong Li, Fei Hou, Xiaohua Zhuo and 9 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The application of artificial intelligence in myopia prediction for children and adolescents: a review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shengsong Xu *State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Linling Li *Department of Ophthalmology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
Yingting ZhuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Zhenbang RuanState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Yiwen QuZhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Zhuandi ZhouDepartment of Ophthalmology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
Yin HuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Zhidong LiState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Fei HouShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
Xiaohua ZhuoShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
Yunxia LengDepartment of Ophthalmology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Xuelin HuangDepartment of Ophthalmology, Guangdong Women and Children Hospital, Guangzhou, China.
Yamei LuDepartment of Ophthalmology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
Zhirong WangDepartment of Ophthalmology, Foshan Women and Children Hospital, Guangzhou, China.
Shuifeng DengDepartment of Ophthalmology, The Second Clinical Medical College of Jinan University, Jinan University, Guangzhou, China.
Yehong ZhuoState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Guoming ZhangShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China. zhang-guoming@163.com.
Min FuDepartment of Ophthalmology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China. 642660719@qq.com.
Xiao YangState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China. yangx_zoc@163.com.

Funding

Guangzhou Municipal Science and Technology Project 2024A03J0336Major Science and Technology Project of Zhongshan City 2022A1007National Natural Science Foundation of China 82171057National Natural Science Foundation of China 82371089Science and Technology Program of Guangzhou, China 202206080005
6 · The paper itself

Abstract

backgroundPrevious Artificial Intelligence (AI) models are mainly based on hospital data to predict myopia progression in myopic children. However, school-level AI models for predicting myopia onset in non-myopic children are lacking. There is a need for more precise and comprehensive tools for full myopia management, from the onset of myopia to its progression.

methodsThis study was conducted in 870 centers dispersed across seven cities in China from September 2019 to December 2021, with participants observed for two years. Machine learning models were trained and internally validated on datasets from Shenzhen, and then externally tested from the other six cities. Of 1,123,602 children and adolescents aged 4-18 years old, 1,105,271 individuals were confirmed eligible. After two-year follow-up, 915,991 individuals were included in analysis. Data were analyzed from June 2022 to July 2023. Main outcomes and measures are the occurrence of myopia, and the change of spherical equivalent refraction in 2 years.

resultsOf 915,991 participants, 405,784 (44.3%) were identified as myopic at baseline. In two years, the occurrence of myopia was 45.5% and the overall myopic shift was - 0.97 ± 1.32D. The optimal machine learning models were established for predicting myopia occurrence in non-myopic individuals; and predicting progression of any amount (defined as an annual progression of < - 0.25D) in myopic individuals. The performance in predicting occurrence (AUC 0.962, 95% CI 0.956-0.968) and progression (AUC 0.923, 95% CI 0.912-0.934) were acceptable in the external test set. The interactions between age and other variables were revealed by the algorithms, and hence the final prediction models were established based on age segmentation. In the external test set, the performance of the models for both 4-11-years (occurrence prediction: AUC 0.978, 95% CI 0.972-0.984; progression prediction: AUC 0.957, 95% CI 0.951-0.963) and 11-18-years age groups (occurrence prediction: AUC 0.966, 95% CI 0.960-0.972; progression prediction: AUC 0.928, 95% CI 0.917-0.939) were improved. Finally, user-friendly software was developed, which makes this model accessible for school use.

conclusionsThe algorithm developed in the current study for predicting myopia occurrence and progression showed excellent performance in school settings using real-world data, indicating its potential application in school-level myopia management. Trial registration chictr.org Identifier: ChiCTR2200057391.

Indexed as

MyopiaSchoolsAdolescentChildChild, PreschoolChinaDisease ProgressionFemaleHumansMachine LearningMaleChildrenMachine learningMyopiaPrediction model

Identifiers

PMID40770756
PMCPMC12330041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.